📢 Too many exams? Don’t know which one suits you best? Book Your Free Expert 👉 call Now!


    Question

    Which company developed the gene therapy ITVISMA for

    spinal muscular atrophy?
    A Pfizer Correct Answer Incorrect Answer
    B Roche Correct Answer Incorrect Answer
    C Novartis Correct Answer Incorrect Answer
    D AstraZeneca Correct Answer Incorrect Answer
    E Johnson & Johnson Correct Answer Incorrect Answer

    Solution

    The report mentions that ITVISMA was developed by Novartis, targeting the genetic cause of spinal muscular atrophy.

    Practice Next

    Relevant for Exams:

    ask-question